R. Williams

711 total citations
21 papers, 557 citations indexed

About

R. Williams is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, R. Williams has authored 21 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Otorhinolaryngology, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in R. Williams's work include Head and Neck Cancer Studies (11 papers), Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). R. Williams is often cited by papers focused on Head and Neck Cancer Studies (11 papers), Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Treatments and Mutations (5 papers). R. Williams collaborates with scholars based in United States, Netherlands and Belgium. R. Williams's co-authors include Everett E. Vokes, Ezra E.W. Cohen, Daniel J. Haraf, Elizabeth A. Blair, James C. Ross, Linda D. Shortliffe, Richard L. Kempson, Matteo Ferrari, Frederick J. Meyers and William C. Pitts and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

R. Williams

21 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Williams United States	14	226	215	157	149	131	21	557
Chonlakiet Khorprasert Thailand	10	206 0.9×	363 1.7×	263 1.7×	240 1.6×	107 0.8×	31	718
Ling S. Wong United Kingdom	15	274 1.2×	286 1.3×	175 1.1×	79 0.5×	64 0.5×	45	604
Jos Nauta Netherlands	8	183 0.8×	232 1.1×	89 0.6×	268 1.8×	81 0.6×	16	566
Qinjing Pan China	15	373 1.7×	202 0.9×	84 0.5×	29 0.2×	130 1.0×	71	813
Steven A. Vasilev United States	17	349 1.5×	159 0.7×	90 0.6×	25 0.2×	83 0.6×	46	1.1k
John M. Kaczmar United States	16	194 0.9×	345 1.6×	121 0.8×	287 1.9×	81 0.6×	55	627
Marlinda Adham Indonesia	9	117 0.5×	308 1.4×	69 0.4×	185 1.2×	122 0.9×	42	563
Chan‐Chao ChangChien Taiwan	17	302 1.3×	138 0.6×	90 0.6×	13 0.1×	94 0.7×	45	856
Anshuma Bansal India	8	108 0.5×	73 0.3×	41 0.3×	46 0.3×	47 0.4×	29	312
C. Frederick LeMaistre United States	5	38 0.2×	351 1.6×	444 2.8×	261 1.8×	87 0.7×	5	702

Countries citing papers authored by R. Williams

Since Specialization

Citations

This map shows the geographic impact of R. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Williams more than expected).

Fields of papers citing papers by R. Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Williams. The network helps show where R. Williams may publish in the future.

Co-authorship network of co-authors of R. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of R. Williams. A scholar is included among the top collaborators of R. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Williams. R. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Villaflor, Victoria, Daniel J. Haraf, Joseph K. Salama, et al.. (2011). Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck. Annals of Oncology. 22(11). 2501–2507. 16 indexed citations

Salama, Joseph K., Daniel J. Haraf, K. M. Stenson, et al.. (2011). A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers. Annals of Oncology. 22(10). 2304–2309. 48 indexed citations

Cohen, Ezra E.W., Daniel J. Haraf, Rangesh Kunnavakkam, et al.. (2010). Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck Cancer. Journal of Clinical Oncology. 28(20). 3336–3343. 64 indexed citations

Cohen, Ezra E.W., Anna B. Halpern, Kristen Kasza, et al.. (2009). Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck. Oral Oncology. 45(10). e155–e160. 38 indexed citations

Puthawala, Ajmel, et al.. (2008). T4 Locally Advanced Head and Neck Cancers Treated with Resection Followed by Radiotherapy or Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone: Outcomes Analysis. International Journal of Radiation Oncology*Biology*Physics. 72(1). S394–S394. 1 indexed citations

Villaflor, Victoria, Ezra E.W. Cohen, D. Haraf, et al.. (2008). Phase II trial pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated head and neck cancer patients. Journal of Clinical Oncology. 26(15_suppl). 6030–6030. 1 indexed citations

Cohen, Ezra E.W., D. Haraf, K. M. Stenson, et al.. (2007). Updated results of a phase II trial integrating gefitinib (G) into concurrent chemoradiation (CRT) followed by G adjuvant therapy for locally advanced head and neck cancer (HNC). Journal of Clinical Oncology. 25(18_suppl). 6028–6028. 13 indexed citations

Choong, Nicholas W., Daniel J. Haraf, Ezra E.W. Cohen, et al.. (2007). Randomized phase II study of concomitant chemoradiotherapy with 5-fluorouracil-hydroxyurea (FHX) compared to FHX and bevazicumab (BFHX) in intermediate stage head and neck cancer (HNC). Journal of Clinical Oncology. 25(18_suppl). 6034–6034. 14 indexed citations

Cohen, Ezra E.W., Daniel J. Haraf, Marcy A. List, et al.. (2006). High Survival and Organ Function Rates After Primary Chemoradiotherapy for Intermediate-Stage Squamous Cell Carcinoma of the Head and Neck Treated in a Multicenter Phase II Trial. Journal of Clinical Oncology. 24(21). 3438–3444. 17 indexed citations

10.

Cohen, Ezra E.W., D. Haraf, K. M. Stenson, et al.. (2005). Integration of gefitinib (G), into a concurrent chemoradiation (CRT) regimen followed by G adjuvant therapy in patients with locally advanced head and neck cancer (HNC) - a Phase II Trial. Journal of Clinical Oncology. 23(16_suppl). 5506–5506. 33 indexed citations

11.

Kruijtzer, C.M.F., Henk Boot, Jos H. Beijnen, et al.. (2003). Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer. Annals of Oncology. 14(2). 197–204. 37 indexed citations

12.

Williams, R., et al.. (1995). Trends in The AIDS Epidemic Among Men Who Reported Sex With Men in New York City: 1981–1993. AIDS Education and Prevention. 7(5 Suppl). 3–12. 8 indexed citations

13.

Stein, Zena, et al.. (1995). Changes Over Time in Survival of Children After AIDS Diagnosis in New York City. American Journal of Preventive Medicine. 11(3). 30–33. 4 indexed citations

14.

Thomas, P., Tejinder Singh, R. Williams, & Steve Blum. (1992). Trends in survival for children reported with maternally transmitted acquired immunodeficiency syndrome in New York City, 1982 to 1989. The Pediatric Infectious Disease Journal. 11(1). 34–38. 28 indexed citations

15.

Jager, Robert De, Eva C. Guinan, Donald L. Lamm, et al.. (1991). Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerin. Urology. 38(6). 507–513. 68 indexed citations

16.

Thomas, P., et al.. (1990). Pediatric Acquired Immunodeficiency Syndrome: An Unusually High Incidence of Twinning. PEDIATRICS. 86(5). 774–777. 6 indexed citations

17.

Torti, Frank M., Linda D. Shortliffe, R. Williams, et al.. (1988). Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.. Journal of Clinical Oncology. 6(3). 476–483. 122 indexed citations

18.

Clayman, Ralph V., Hēnry Buchwald, Richard L. Varco, William C. DeWolf, & R. Williams. (1978). Urolithiasis in patients with a jejunoileal bypass.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 147(2). 225–30. 14 indexed citations

19.

Williams, R., et al.. (1964). Vaginal reconstruction following pelvic exenteration for cancer or post-irradiation necrosis. Plastic & Reconstructive Surgery. 34(6). 644–644. 7 indexed citations

20.

Youmans, Julian R., et al.. (1964). Experimental evaluation of a Teflon tendon prosthesis. Plastic & Reconstructive Surgery. 34(6). 644–644. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact